Dian-Jang Lee, D.V.M., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 8 | 2019 | 3433 | 1.610 |
Why?
|
| Folate Receptor 1 | 1 | 2019 | 40 | 0.640 |
Why?
|
| Gene Silencing | 5 | 2019 | 1507 | 0.600 |
Why?
|
| Folic Acid Transporters | 2 | 2017 | 2 | 0.590 |
Why?
|
| Polyethylene Glycols | 3 | 2019 | 1188 | 0.580 |
Why?
|
| Folic Acid | 3 | 2019 | 1309 | 0.550 |
Why?
|
| Polymers | 4 | 2019 | 1615 | 0.490 |
Why?
|
| Nanocapsules | 1 | 2015 | 92 | 0.480 |
Why?
|
| Folate Receptors, GPI-Anchored | 3 | 2018 | 23 | 0.440 |
Why?
|
| Molecular Biology | 1 | 2015 | 580 | 0.370 |
Why?
|
| RNA Interference | 2 | 2017 | 2836 | 0.360 |
Why?
|
| Drug Delivery Systems | 2 | 2019 | 2211 | 0.350 |
Why?
|
| Leukemia | 1 | 2017 | 1519 | 0.330 |
Why?
|
| Methotrexate | 1 | 2015 | 1719 | 0.320 |
Why?
|
| Mice, Nude | 4 | 2018 | 3602 | 0.280 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 3609 | 0.240 |
Why?
|
| Peptides | 1 | 2015 | 4341 | 0.220 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 16886 | 0.210 |
Why?
|
| Drug Carriers | 2 | 2017 | 705 | 0.200 |
Why?
|
| Genes, Reporter | 2 | 2015 | 1527 | 0.190 |
Why?
|
| Neoplasms | 3 | 2019 | 22030 | 0.180 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2021 | 507 | 0.150 |
Why?
|
| Click Chemistry | 1 | 2018 | 95 | 0.150 |
Why?
|
| Lipids | 3 | 2018 | 3326 | 0.150 |
Why?
|
| KB Cells | 1 | 2015 | 13 | 0.130 |
Why?
|
| Tissue Distribution | 2 | 2018 | 2263 | 0.120 |
Why?
|
| RNA Stability | 1 | 2017 | 331 | 0.120 |
Why?
|
| Cations | 1 | 2015 | 238 | 0.120 |
Why?
|
| Sulfhydryl Compounds | 1 | 2016 | 297 | 0.120 |
Why?
|
| Luciferases | 1 | 2016 | 714 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 1895 | 0.100 |
Why?
|
| Microfluidics | 1 | 2017 | 652 | 0.100 |
Why?
|
| Random Allocation | 1 | 2015 | 2385 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 2057 | 0.090 |
Why?
|
| Nanostructures | 1 | 2015 | 547 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2015 | 2905 | 0.080 |
Why?
|
| Transfection | 1 | 2015 | 5779 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3574 | 0.070 |
Why?
|
| Animals | 7 | 2021 | 167777 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2017 | 1940 | 0.060 |
Why?
|
| Cell Survival | 1 | 2015 | 5781 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2330 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 2016 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12760 | 0.050 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2021 | 72 | 0.050 |
Why?
|
| Cell Line | 1 | 2015 | 15594 | 0.050 |
Why?
|
| Aptamers, Nucleotide | 1 | 2021 | 163 | 0.040 |
Why?
|
| Humans | 9 | 2021 | 758381 | 0.040 |
Why?
|
| Azides | 1 | 2018 | 118 | 0.040 |
Why?
|
| Static Electricity | 1 | 2018 | 261 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 320 | 0.040 |
Why?
|
| Female | 5 | 2021 | 390316 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 81107 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2021 | 1254 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 398 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2021 | 1533 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1893 | 0.030 |
Why?
|
| Particle Size | 1 | 2018 | 1641 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 2021 | 949 | 0.030 |
Why?
|
| Cell Death | 1 | 2018 | 1667 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 2222 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2021 | 2553 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2796 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2016 | 2413 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 4641 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8506 | 0.020 |
Why?
|